Phosphatase of regenerating liver‐3 promotes migration and invasion by upregulating matrix metalloproteinases‐7 in human colorectal cancer cells
Open Access
- 30 November 2011
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 131 (3) , E190-E203
Abstract
Phosphatase of regenerating liver (PRL)‐3, a member of a subgroup of protein tyrosine phosphatases that can stimulate the degradation of the extracellular matrix, is over‐expressed in metastatic colorectal cancer (CRC) relative to primary tumors. To determine whether PRL‐3‐induced enhancement of migration and invasion is dependent on the expression of matrix metalloproteinases (MMPs), PRL‐3 was expressed in DLD‐1 human CRC cells. The motility, migration and invasion characteristics of the cells were examined, and metastasis to the lung was confirmed in a nude mouse using PRL‐3‐overexpressing DLD‐1 cells [DLD‐1 (PRL‐3)]. Migration and invasion of the cells were inhibited by phosphatase and farnesyltransferase inhibitors. Expression of MMPs was enhanced 3‐ to 10‐fold in comparison to control cells, and migration and invasion were partially inhibited by small interfering RNA (siRNA) knockdown of MMP‐2, ‐13 or ‐14. Importantly, siRNA knockdown of MMP‐7 completely inhibited the migration and invasion of DLD‐1 (PRL‐3) cells, whereas overexpression of MMP‐7 increased migration. The expression of MMP‐7 was also downregulated by phosphatase and farnesyltransferase inhibitors. It was found that PRL‐3 induced MMP‐7 through oncogenic pathways including PI3K/AKT and ERK and that there is a relationship between the expression of PRL‐3 and MMP‐7 in human tumor cell lines. The expression of MMP‐13 and ‐14 was very sensitive to the inhibition of farnesyltransferase; however, the migration and invasion of DLD‐1 (PRL‐3) cells did not strongly depend on the expression of MMP‐13 or ‐14. These results suggest that the migration and invasion of PRL‐3‐expressing CRC cells depends primarily on the expression of MMP‐7.Keywords
This publication has 32 references indexed in Scilit:
- Phosphatase of regenerating liver‐3 as a convergent therapeutic target for lymph node metastasis in esophageal squamous cell carcinomaInternational Journal of Cancer, 2010
- A Selective Phosphatase of Regenerating Liver Phosphatase Inhibitor Suppresses Tumor Cell Anchorage-Independent Growth by a Novel Mechanism Involving p130Cas CleavageCancer Research, 2008
- PRL PTPs: mediators and markers of cancer progressionCancer and Metastasis Reviews, 2008
- Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cellsBlood, 2008
- Expression of Matrix Metalloproteinase-7 on Cancer Cells and Tissue Endothelial Cells in Renal Cell Carcinoma: Prognostic Implications and Clinical Significance for Invasion and MetastasisClinical Cancer Research, 2006
- Crystallographic Analysis of CaaX Prenyltransferases Complexed with Substrates Defines Rules of Protein Substrate SelectivityJournal of Molecular Biology, 2004
- The association of the expression level of protein tyrosine phosphatase PRL-3 protein with liver metastasis and prognosis of patients with colorectal cancerJournal of Cancer Research and Clinical Oncology, 2004
- Dissemination and growth of cancer cells in metastatic sitesNature Reviews Cancer, 2002
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002
- Role of PRL-3, a Human Muscle-Specific Tyrosine Phosphatase, in Angiotensin-II SignalingBiochemical and Biophysical Research Communications, 2001